Edwards Lifesciences Corp 4
4 · Edwards Lifesciences Corp · Filed May 19, 2011
Insider Transaction Report
Form 4
REINDL ROBERT C
CVP, H.R. and Communications
Transactions
- Exercise/Conversion
Common Stock
2011-05-18$3.19/sh+136$433→ 7,917 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2011-05-18−152→ 0 totalExercise: $3.20From: 2003-03-30Exp: 2012-09-30→ Common Stock (152 underlying) - Exercise/Conversion
Common Stock
2011-05-18$2.89/sh+150$434→ 7,781 total - Exercise/Conversion
Common Stock
2011-05-18$3.42/sh+182$623→ 7,479 total - Exercise/Conversion
Common Stock
2011-05-18$3.20/sh+152$486→ 7,631 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2011-05-18−46→ 0 totalExercise: $3.50From: 2002-09-28Exp: 2012-03-28→ Common Stock (46 underlying) - Exercise/Conversion
Common Stock
2011-05-18$3.50/sh+46$161→ 7,963 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2011-05-18−136→ 0 totalExercise: $3.19From: 2003-06-30Exp: 2012-12-31→ Common Stock (136 underlying) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2011-05-18−182→ 0 totalExercise: $3.42From: 2003-09-30Exp: 2013-03-31→ Common Stock (182 underlying) - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2011-05-18−150→ 0 totalExercise: $2.89From: 2002-12-28Exp: 2012-06-28→ Common Stock (150 underlying) - Sale
Common Stock
2011-05-18$89.50/sh−666$59,607→ 7,297 total
Footnotes (1)
- [F1]This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.